血脂异常诊治研究进展  

Research progress in diagnosis and treatment of dyslipidemia

作　　者：陈昕怡 陈佳丽[1] 沈传斌 CHEN Xinyi;CHEN Jiali;SHEN Chuanbin(Department of Cardiovascular and Vascular Medicine,School of Clinical Stomatology,Hangzhou Normal University,Hangzhou,Zhejiang 311100,China)

机构地区：[1]杭州师范大学临床口腔医学院心血管内科,浙江杭州311100

出　　处：《医药前沿》2024年第31期35-37,共3页Journal of Frontiers of Medicine

摘　　要：冠状动脉粥样硬化性心脏病(简称冠心病)是全球第一致死原因,冠心病的诊治中,血脂控制是较为重要的一环。本文从血脂异常病因、管理目标、药物治疗等方面展开综述,以期为临床医生提供最新信息,指导临床用药。Coronary atherosclerotic heart disease(coronary heart disease)is the first cause of death in the world.In the diagnosis and treatment of coronary heart disease,blood lipid control is a more important part.This article discusses the causes of dyslipidemia,management objectives and drug therapy of dyslipidemia,in order to provide the latest information for clinicians and guide clinical drug use.

关 键 词：血脂代谢 降脂 胆固醇 三酰甘油 新型降脂药物 

分 类 号：R322[医药卫生—人体解剖和组织胚胎学]